Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

PENUMBRA, INC.

(PEN)
  Report
Delayed Quote. Delayed Nyse - 01/27 07:00:00 pm
197.49 USD   -5.64%
01/14INSIDER SELL : Penumbra
MT
01/10PENUMBRA : Regulation FD Disclosure - Form 8-K
PU
01/10PENUMBRA INC : Regulation FD Disclosure (form 8-K)
AQ
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
01/21/2022 01/24/2022 01/25/2022 01/26/2022 01/27/2022 Date
218.3(c) 228.46(c) 213.07(c) 209.29(c) 197.49 Last
150 501 265 955 264 833 135 705 188 010 Volume
-2.24% +4.65% -6.74% -1.77% -5.64% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 738 M - -
Net income 2021 16,3 M - -
Net Debt 2021 - - -
P/E ratio 2021 454x
Yield 2021 -
Sales 2022 862 M - -
Net income 2022 55,5 M - -
Net Debt 2022 - - -
P/E ratio 2022 135x
Yield 2022 -
Capitalization 7 378 M 7 378 M -
Capi. / Sales 2021 10,00x
Capi. / Sales 2022 8,56x
Nbr of Employees 3 300
Free-Float 95,6%
More Financials
Company
Penumbra, Inc. is a global healthcare company. The Company is engaged in the design, development, manufacturing, and marketing of medical devices. It is focused on developing and building its portfolio of products, including its thrombectomy, embolization and access technologies. The Company's neuro products include Thrombectomy, Embolization, Neurovascular access, Neurosurgical Tools, and Virtual Reality Platform.... 
More about the company
Ratings of Penumbra, Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
B-
More Ratings
All news about PENUMBRA, INC.
01/14INSIDER SELL : Penumbra
MT
01/10PENUMBRA : Regulation FD Disclosure - Form 8-K
PU
01/10PENUMBRA INC : Regulation FD Disclosure (form 8-K)
AQ
01/10Penumbra Says Not in Talks With Shockwave Medical About Potential Merger
MT
01/06INSIDER SELL : Penumbra
MT
2021Penumbra, Inc. to Present at the 40th Annual J.P. Morgan Healthcare Conference
PR
2021INSIDER SELL : Penumbra
MT
2021New Data Demonstrates Safety and Performance of Continuous Aspiration Thrombectomy with..
BU
2021Penumbra, Inc. Announces CHEETAH Clinical Study of Indigo? System CAT? RX Catheter
CI
2021PENUMBRA : Q3 Earnings Snapshot
AQ
2021PENUMBRA INC MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS ..
AQ
2021Penumbra, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended Sep..
CI
2021Penumbra, Inc. Reports Third Quarter 2021 Financial Results - Form 8-K
PU
2021Penumbra Swings to Adjusted Earnings in Q3, Lifts 2021 Revenue Outlook
MT
2021Earnings Flash (PEN) PENUMBRA Posts Q3 EPS $0.12, vs. Street Est of $0.17
MT
More news
News in other languages on PENUMBRA, INC.
01/10Penumbra affirme ne pas être en pourparlers avec Shockwave Medical au sujet d'une fusio..
01/06VENTE D'INITIÉS : Penumbra
2021Penumbra dégage un bénéfice ajusté au troisième trimestre et relève ses prévisions de r..
2021Earnings Flash (PEN) PENUMBRA affiche un chiffre d'affaires de 190,1 millions de dollar..
2021Penumbra, Inc. met à jour ses prévisions de revenus pour l'année 2021
More news
Analyst Recommendations on PENUMBRA, INC.
More recommendations
Chart PENUMBRA, INC.
Duration : Period :
Penumbra, Inc. Technical Analysis Chart | PEN | US70975L1070 | MarketScreener
Technical analysis trends PENUMBRA, INC.
Short TermMid-TermLong Term
TrendsBearishBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 7
Last Close Price 197,49 $
Average target price 323,17 $
Spread / Average Target 63,6%
EPS Revisions
Managers and Directors
Adam Elsesser Chairman, President & Chief Executive Officer
Maggie S. Yuen Chief Financial Officer
Pankaj Tiwari Vice President-Information Technology
Michaella Corso Vice President-Clinical Affairs
Corey L. Teigen Chief Scientific Officer
Sector and Competitors
1st jan.Capi. (M$)
PENUMBRA, INC.-27.16%7 819
MASIMO CORPORATION-27.26%11 345
GETINGE AB-15.01%9 869
NOVOCURE LIMITED-16.10%6 540
ASAHI INTECC CO., LTD.-18.78%4 768
JIANGSU YUYUE MEDICAL EQUIPMENT & SUPPLY CO., LTD.-21.01%4 762